CCN2 and cancer: experimental and clinical data have proved that angiogenic factors vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), connective tissue growth factor (CTGF), endothelia (ET-1) and angiopoietins(Ang1/Ang2) stimulates normal vessel excessive growth contribute to cancer progression [2].